Exact Sciences Corp (NAS:EXAS)
$ 52.21 -1.31 (-2.45%) Market Cap: 9.63 Bil Enterprise Value: 11.78 Bil PE Ratio: 0 PB Ratio: 3.06 GF Score: 78/100

Exact Sciences Corp at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 07:15PM GMT
Release Date Price: $70.57 (-3.59%)
Rachel Marie Vatnsdal Olson
JPMorgan Chase & Co, Research Division - Analyst

Hi. Good morning or good afternoon, everyone. This is Rachel Vatnsdal with the life science tools and diagnostics team. I'm joined today by the Exact Sciences' management team. As is typical, this will be roughly a 20-minute presentation followed by 20 minutes of Q&A. We have mic runners in the room. So if any of you have a question, feel free to raise your hand. Otherwise, you can submit your questions via the app or just ping me directly. With that, Kevin, I will let you take it off.

Kevin T. Conroy
Exact Sciences Corporation - Chairman of The Board & CEO

Thank you, Rachel, and welcome, everybody, and welcome to all who are listening via the webcast. We all have a story about a fight to defeat cancer, whether it is a loved one, whether it's a friend, a colleague or ourselves. Cancer is the #1 cause of death for people under age 85. That's just about everybody in this room. And if we detect cancer earlier when it's most treatable, we know that's the start of defeating

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot